Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orafang vs 2L-PEG/Asc for Bowel Preparation in Elderly
NCT05249335Phase 4Unknown
- Sponsor
- Pharmbio Korea Inc.
- Start
- Feb 2022
- Primary completion
- Feb 2024
- Modality
- Drug Delivery Systems
01
Overview
Phase 4, randomised, single-blind trial of Orafang in bowel preparation (2 arms), sponsored by Pharmbio Korea Inc. Primary endpoints: Successful cleaning rate 1 (Boston Bowel Preparation Scale) at 2 days and Successful cleaning rate 2 (Harefield Cleansing Scale) at 2 days. Status: unknown.
02
Drugs
Orafang
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT05249335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249335.